PB2200: FOOD AND ACID REDUCING AGENT EFFECTS ON PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF THE COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) TL-895 IN HEALTHY SUBJECTS

• Martine Allard,
• Cecile Krejsa,
• Isaiah Williams,
• Terry Podoll,
• Kim Steinmann,
• Greg Slatter

Affiliations

Martine Allard

1 Telios Pharma, Inc., Redwood City, United States

Cecile Krejsa

1 Telios Pharma, Inc., Redwood City, United States

Isaiah Williams

1 Telios Pharma, Inc., Redwood City, United States

Terry Podoll

1 Telios Pharma, Inc., Redwood City, United States

Kim Steinmann

1 Telios Pharma, Inc., Redwood City, United States

Greg Slatter

1 Telios Pharma, Inc., Redwood City, United States